AI in Healthcare: Which Sources AI Engines Actually Cite When Buyers Research Health AI Platforms

AI healthcare companies operate in a category where editorial credibility is a regulatory and commercial prerequisite, not a growth accelerator. When a health system, a payer or a procurement team asks ChatGPT, Perplexity or Google AI Mode which AI platforms to trust, the answer is assembled from whatever those engines can find, extract and attribute. Health AI PR plans usually describe that source set as five layers of roughly equal weight: peer-reviewed journals, tier-one business media, the healthcare trade press, the analyst firms and the regulatory databases. The Machine Relations Index can now measure each layer for healthcare, and the measurement is not five equal layers. On healthcare news questions the engines cite NIH first at 25.12% of 613 answer runs, then Fierce Healthcare, then the digital health analyst firms; the journals' own domains, the business titles and the FDA are each cited in ten runs or fewer. On the three healthcare buyer questions the Index has published, 29 of the 30 top-ten slots are healthcare companies' own pages (the thirtieth is Becker's Hospital Review), and the AI-native vendors that reach those answers are the ones with a plain product page on their own domain, not the ones with the most coverage. This page covers what that means for a health AI company: which layer is actually the citation layer, where the famous clinical-AI names stand in the release, and the five-layer plan rebuilt on the evidence.

Key Takeaways for Health AI Companies

• The most-cited healthcare source is not a publication, a business title or a regulator. In the healthcare services news segment (613 runs across 53 dates, 1,264 cited domains), NIH is #1 at 25.12%, Fierce Healthcare #2 at 19.09%, Galen Growth #3 at 12.72%, the American Hospital Association #4, LinkedIn #5, Y Combinator #6, Healthcare Dive #7, Rock Health #8. A peer-reviewed paper indexed at PubMed Central lands on the domain the engines cite most; the journal's own domain barely registers (nature.com is #97, cited in 10 runs).
• The tier-one business layer is the thinnest of the five. Forbes is #47 on healthcare news (15 runs of 613), Business Insider #107 (9), TechCrunch #576 (2), WIRED #1,226 (1). The healthcare trade press this page listed as a third layer is the actual editorial citation layer: Fierce Healthcare 117 runs, Healthcare Dive 43, Becker's 35, MedCity News 33.
• The analyst layer is real, but it is the digital health analysts, not the big four. Galen Growth (#3), Rock Health (#8) and CB Insights (#12) are cited above every publication except Fierce; Deloitte is #42, Gartner #145, McKinsey #184, and Forrester is not observed in any healthcare segment.
• The regulatory record is cited less than the page assumed. fda.gov is cited in 7 of the Index's 15,883 monitored runs in total and in 6 healthcare news runs (#175 of 1,264). CMS is the regulator the engines actually cite: cms.gov is #20 on healthcare news and #36 on how buyers choose.
• Buyer questions are not answered from any of the five layers. On best tools, how buyers choose and top lists, 29 of the 30 top-ten slots are healthcare companies' own domains (Becker's at rank 9 on best tools is the exception), and the AI-branded vendor domains inside those top forties (rapidclaims.ai, exactrx.ai, getperspective.ai, deepcura.com, getfreed.ai, patientnotes.ai, getprosper.ai) got there with their own pages, while Viz.ai, Hippocratic AI, Nuance, OpenEvidence, Ambience, Nabla and Suki are not observed anywhere in the 22,213-domain release.
• The plan is still five layers, with the weights changed: an owned page per buyer question first, because that is what buyer answers are made of; publication indexed at NIH for the clinical evidence; the healthcare trade press and digital health analysts in the order the engines cite them; entity clarity across all of it; and measurement at the Index rather than by domain authority.

The Healthcare AI Visibility Problem Is Structural, Not Promotional

Healthcare AI companies face a visibility gap that generic PR cannot close. A 2025 analysis of 3,560 US hospitals found that AI implementation is geographically clustered, with adoption driven by local institutional characteristics rather than product quality alone (npj Health Systems). Buyers in this category do not discover tools through advertising. They discover them through peer-reviewed validation, analyst coverage and, increasingly, AI-mediated research.

The problem compounds when AI engines try to evaluate healthcare AI companies. A survey of 914 healthcare stakeholders across 143 countries identified "Blind Trust" as the first of seven systemic failure modes in medical AI, which means trust signals must be independently verifiable, not self-declared (Müller et al., npj Digital Medicine, 2026). If a company's trust evidence is locked in pitch decks and press releases that AI engines cannot parse, the company does not exist in the AI-mediated buyer journey.

What the Index adds is a measurement of where the engines actually go for that evidence, and it is narrower than the five-layer picture suggested.

What the Five Layers Measure At

The Index monitors six answer engines (ChatGPT, Claude, Gemini, Google AI Mode, Google AI Overviews and Perplexity) on buyer prompts and records which root domains each answer cites. Release mri_score_v2.0+2026-09-19+0cad03121f60 covers 2026-05-10 to 2026-09-19, 15,883 monitored runs and 22,213 cited domains. The healthcare services category has four question shapes published and three collecting, and health AI has no category of its own, so healthcare services is the measurement this page uses. Here is each of those layers, with where its examples land on healthcare news and on the published buyer shapes.

Layer as the page described it	Examples the page named	Healthcare news (of 1,264 sources, 613 runs)	Healthcare buyer shapes
Peer-reviewed journals, "weighted heavily for clinical claims"	Nature Medicine, npj Digital Medicine, The Lancet Digital Health, JAMA	nature.com #97 (10 runs); nejm.org #1,021 (1); thelancet.com not observed in the release; jamanetwork.com not on news. The evidence host the engines cite is NIH at #1 (154 runs), with sciencedirect.com #23 (24)	NIH rank 14 of 214 on how buyers choose (8 of 107 runs) and 28 of 101 collecting is-it-worth-it runs; jamanetwork.com 4 of 101 on the same collecting shape
Tier-one business media, "investor and executive discovery layer"	TechCrunch, Forbes, Business Insider, WIRED	Forbes #47 (15); Business Insider #107 (9); TechCrunch #576 (2); WIRED #1,226 (1)	Forbes rank 16 of 199 on best tools (7 of 107 runs) and rank 164 of 223 on top lists (1 of 102); the other three not observed on any buyer shape
Healthcare trade press, "procurement and clinical decision-maker attention"	STAT News, MedCity News, Fierce Healthcare, Healthcare IT News	Fierce Healthcare #2 (117); Healthcare Dive #7 (43); Becker's #13 (35); MedCity News #14 (33); HealthTech Magazine #29 (20); Healthcare IT Today #55 (14); MedTech Dive #70 (12); STAT #71 (12); Healthcare IT News #148 (7)	Becker's rank 9 of 199 on best tools (13 of 107 runs); Healthcare IT News rank 90 (2 of 107); STAT 11 of 101 collecting is-it-worth-it runs, the most of any trade title on a buyer shape
Analyst research, "enterprise shortlisting and board-level validation"	Gartner, Forrester, McKinsey, Deloitte	Galen Growth #3 (78); Rock Health #8 (42); CB Insights #12 (37); Bessemer #41 (16); Deloitte #42 (16); PwC #82 (11); Gartner #145 (7); McKinsey #184 (6); Forrester not observed in any healthcare segment	Gartner rank 25 of 199 on best tools (6 of 107 runs), rank 158 of 214 on how buyers choose (1 of 107), rank 166 of 223 on top lists (1 of 102); no other analyst domain inside a published healthcare buyer top 100
Regulatory databases, "trust verification by both humans and machines"	FDA AI/ML device list, CMS program announcements	cms.gov #20 (25); hhs.gov #31 (19); ahrq.gov #40 (16); healthit.gov #65 (13); fda.gov #175 (6)	cms.gov rank 36 of 214 on how buyers choose (4 of 107 runs); medicaid.gov rank 38 (4 of 107); fda.gov not observed on any buyer shape

Three of the five layers hold up in some form, and two do not. The journals hold up only through NIH: a paper's PubMed Central listing is the single most-cited kind of healthcare evidence, and the journal's own domain is not, which changes what "publish the study" means for a health AI company. The trade press and the analysts hold up, in a different order from the one the page gave: Fierce, Healthcare Dive, Becker's and MedCity are the editorial citation layer, and Galen Growth, Rock Health and CB Insights outrank every big-four firm. The business titles do not hold up: the four named here are cited in 27 healthcare news runs between them against Fierce Healthcare's 117. And the regulatory layer is the FDA on paper and CMS in practice: fda.gov is cited in 7 runs across the entire Index, while cms.gov reaches both healthcare news and the how-buyers-choose shape.

Where the Health AI Companies Themselves Stand

A common diagnosis is that a health AI company's peer-reviewed papers exist but the entity chain connecting them to the company is broken. The release lets that be checked company by company, because each cited domain has a profile listing every segment it was observed in.

Company domain	Whole-Index standing (of 15,883 runs)	Healthcare news (of 1,264)	Engines observed citing it
tempus.com	22 runs, collecting	#26, 3.59% (22 runs)	6 of 6
intuitionlabs.ai	38 healthcare news runs	#11, 6.20%	on the segment page
aidoc.com	11 runs, collecting	#88, 1.63% (10 runs)	4 (Gemini, Google AI Mode, Google AI Overviews, Perplexity)
epic.com	2 runs, collecting	#451, 0.33% (2 runs)	1 (Google AI Mode)
abridge.com	1 run, collecting	#620, 0.16% (1 run)	1 (Google AI Mode)
viz.ai, hippocraticai.com, nuance.com, openevidence.com, ambiencehealthcare.com, nabla.com, suki.ai	Not observed in the 22,213-domain release	Not observed	None

Among the companies in the table, Tempus is the one the engines cite most on healthcare news, from all six engines, on its own domain, and intuitionlabs.ai at rank 11 sits above it. Abridge is cited once. Seven of the best-known names in the category are not observed as a cited source in any of 15,883 runs. That is the entity-chain problem measured: coverage volume and citation are different things, and a company can be everywhere in the trade press and absent from the answers.

On the buyer shapes the pattern inverts in an instructive way. The AI-branded vendors that do reach healthcare buyer answers are not the clinical-AI names above. On best tools, rapidclaims.ai is rank 8 of 199 (14 of 107 runs) and exactrx.ai rank 12 (12 of 107). On top lists, getperspective.ai is rank 5 of 223 (13 of 102 runs), deepcura.com rank 8 (11 of 102), getfreed.ai rank 17 (8 of 102) and patientnotes.ai rank 29 (6 of 102). On how buyers choose, getprosper.ai is rank 9 of 214 (9 of 107 runs) and lunacal.ai rank 31 (5 of 107). On the still-collecting is-it-worth-it shape, getfreed.ai is cited in 13 of 101 runs and patientnotes.ai in 11, behind only NIH and the American Medical Association. Every one of those is a company's own domain answering the buyer's question directly. None of them is in the top 100 of the news segment.

Why This Category Demands a Different Approach Than SaaS or Fintech

Most technology categories can build visibility through standard earned media and SEO. Healthcare AI cannot, for three reasons the measurement sharpens.

1. Regulatory trust is table stakes, not a differentiator, and it is not a citation either. A taxonomy of AI use across 1,016 FDA-authorized medical devices found radiology accounting for the largest share (Singh et al., npj Digital Medicine, 2025). FDA clearance is necessary to sell, and the Index shows the FDA's own database is cited in 7 runs of 15,883, so a clearance is not something the engines read from fda.gov. The clearance has to be stated, in context, on a page the engines do cite: your own domain, a trade title, or a paper.

2. Clinical credibility must survive peer review, and it has to be indexed where the engines look. Nature Medicine reported in March 2026 that AI models are moving from conversational tools to hypothesis generators validated in organoids, animal models and early clinical trials (Nature Medicine, 2026). A health AI company that produces or is cited in that research earns citation authority, but through NIH's index of it (25.12% of healthcare news runs), not through the journal's domain (nature.com 1.63%).

3. Governance frameworks are the new buying criteria. A systematic review of 35 healthcare AI governance frameworks introduced HAIRA, a maturity model health systems can score at the system or service-line level (Hussein et al., npj Digital Medicine, 2026). A company that cannot state its governance maturity on a page the engines read is invisible to the procurement workflows that use it, and the pages the engines read for how-buyers-choose questions are the vendors' own (omnimd.com leads that shape at 14.95% of 107 runs, and the first source in it that is not a company's own site is NIH at rank 14 of 214).

Why Generic PR Fails Healthcare AI Companies

Traditional PR in healthcare follows a predictable pattern: hire a health-tech PR agency, issue press releases around funding rounds and FDA clearances, pitch STAT and Fierce Healthcare, wait for coverage. The Index shows three ways that misses.

The editorial surface has expanded beyond human journalists. When a hospital CTO asks Perplexity which AI platforms have the certifications and clearances they need, the answer is assembled from the sources the engines read for that question shape. For healthcare buyer questions those sources are vendors' own pages, NIH and, on how buyers choose, CMS; the press release wire is at #72 on healthcare news (Business Wire, 11 runs) and nowhere on the buyer shapes. If a company's trust evidence is scattered across PDFs, releases and investor decks, the engines cannot synthesize it.

Healthcare AI buyers verify through multiple independent sources. Trust in AI-assisted healthcare is bidirectional: patients trust providers who trust the technology, and that chain depends on independent corroboration (npj Health Systems, 2025). A single Forbes feature does not build that chain, and the Index puts a number on it: Forbes is cited in 15 healthcare news runs of 613. A corroborated presence across NIH, the trade press and the company's own domain does.

The clinical-commercial gap kills visibility. Healthcare AI companies publish rigorous research under academic conventions (institution names, principal investigators) while marketing under brand names and product labels. The engines see two disconnected entities, and the domain profiles show the result: a company can be the subject of a PubMed-indexed study and hold one cited run on its own domain. Machine Relations closes this gap by building a unified entity chain that connects clinical evidence to commercial identity.

How Machine Relations Works for Healthcare AI

Machine Relations is the discipline of earning AI citations and recommendations for a brand by making that brand legible, retrievable and credible inside AI-driven discovery systems. For healthcare AI companies, on the evidence above, this means:

Layer 1: Owned buyer pages. One page on your own domain for each buyer question the Index publishes for healthcare (best tools, how to choose, top lists, and, as they publish, is it worth it, problem-first and comparisons), each written to the FTC substantiation line with clearance, certification and governance maturity stated in plain terms. This is the only layer that reaches buyer answers; 29 of the 30 published healthcare buyer top-ten slots are made of it.

Layer 2: Earned authority, in the order the engines cite it. Publication in the sources the healthcare segments show the engines reading: a paper indexed at NIH for the clinical evidence, the healthcare trade press (Fierce Healthcare, Healthcare Dive, Becker's, MedCity News) for the news answers, and the digital health analysts (Galen Growth, Rock Health, CB Insights) whose reports are cited above every publication except Fierce. Stacker and Scrunch's pilot on earned versus owned citation rates, reported on Machine Relations, holds on healthcare news; on healthcare buyer questions the measurement is the reverse, and the plan has to carry both.

Layer 3: Entity clarity. Connect the company name, product names, clinical evidence, regulatory status and leadership into a single resolvable entity that the engines identify and attribute consistently. This is entity optimization: the paper, the clearance and the product page resolve to one company.

Layer 4: Citation architecture. Structure clinical evidence, regulatory milestones and commercial claims so that each is independently extractable and attributable. The engines extract structured, sourced claim blocks, not narrative prose (citability doctrine), and the citation architecture is what lets an engine connect a PubMed listing to the company that built the technology.

Layer 5: Measurement and recursion. Track AI visibility across the six engines the Index monitors, read your own domain profile for which healthcare shapes cite you and at what rate, measure share of citation against the vendors that hold the buyer slots, and feed the result back into the editorial plan. Tempus's profile (six engines, 22 runs) and Abridge's (one engine, 1 run) are the two ends of what that measurement looks like today.

The Competitive Window

Healthcare AI funding hit its highest first-quarter total since the pandemic in 2026, with AI companies capturing the bulk of it, and CMS launched ACCESS, a ten-year Medicare program testing AI-enabled care delivery with 150 participants (TechCrunch, May 2026; CMS). The category is consolidating faster than the editorial footprint around it, and the Index shows how little of that footprint has reached the answers: of the twelve health AI company domains checked here, one is cited from all six engines and seven are not cited at all.

The companies that build the owned pages and the entity chain now, before the healthcare buyer shapes finish publishing (three of six are live, three are one or two run dates short), will be the ones the engines cite by default when a buyer asks which AI healthcare platform to trust. The companies that wait will compete on product alone, in a category where trust is the product.

Approach	What it optimizes	What the Index shows it misses
Traditional healthcare PR	Human journalist coverage	Buyer answers, where 29 of 30 published healthcare top-ten slots are companies' own pages
Healthcare SEO	Google organic ranking	The healthcare news answers, which run through NIH, the trade press and the analysts
Content marketing	Brand-owned traffic	The entity chain that lets an engine connect a paper at NIH to the company that built it
Machine Relations	Owned buyer pages, earned authority in the engines' order, entity clarity, citation architecture, measurement at the Index	Whatever the next release shows; the Index is the check, not the claim

The same measurement applied to the whole category is on the healthcare hub, to device companies on the MedTech page, and to the two-track press plan on the healthcare PR strategy page.

FAQ

What is Machine Relations for healthcare AI companies?

Machine Relations is the discipline of earning AI citations and recommendations by making a healthcare AI brand legible, retrievable and credible inside AI-driven discovery systems. It was coined by Jaxon Parrott, founder of AuthorityTech, in 2024. In healthcare the Index shows it means two things at once: owned pages written to each buyer question, because those answers are built from healthcare companies' own domains, and publication in the sources the engines actually read for healthcare news, which are NIH, the healthcare trade press and the digital health analysts rather than the journals' own domains, the business titles or the FDA.

Why can't healthcare AI companies rely on traditional PR?

Because the answers buyers get are not assembled from the coverage PR produces. On healthcare news questions the engines cite NIH in 25.12% of 613 runs and Fierce Healthcare in 19.09%, while Forbes is cited in 15 runs, TechCrunch in 2 and the press-release wire in 11. On healthcare buyer questions (best tools, how to choose, top lists) 29 of the 30 top-ten slots are healthcare companies' own pages, and Becker's at rank 9 on best tools is the only trade title inside one. Coverage shapes the news answers; owned pages shape the buyer answers; a PR program alone produces only the first.

How does FDA clearance affect AI visibility?

FDA clearance is necessary to sell and is not, by itself, a citation. fda.gov is cited in 7 of the Index's 15,883 monitored runs and in 6 healthcare news runs of 613; it is not observed on any published healthcare buyer shape. The regulator the engines do cite is CMS, at #20 on healthcare news and #36 on how buyers choose. A clearance affects visibility when it is stated on a page the engines read for the buyer's question, which in healthcare is the company's own domain, and when the entity chain connects that page to the cleared device and the evidence behind it.

How do AI engines evaluate trust in healthcare AI companies?

The survey of 914 stakeholders across 143 countries that named "Blind Trust" the first systemic risk in medical AI (Müller et al., npj Digital Medicine, 2026) is the human side. The machine side, measured, is that the engines take healthcare evidence from NIH first (#1 on news, #14 on how buyers choose), from the healthcare trade press and the digital health analysts next, and from a company's own pages on buyer questions. A health AI company builds the independent verification layer by being present on those sources under one resolvable identity, and it checks the result at its own Index profile rather than inferring it from coverage.

What is share of citation for healthcare AI?

Share of citation is the percentage of AI-generated responses that cite a specific brand when answering a relevant query. For a healthcare AI company it is read per question shape, because the shapes disagree: a company can hold a top-ten slot on top lists and be unobserved on how buyers choose. The Index reports it as a citation rate per segment (omnimd.com 32.71% of 107 best-tools runs; Tempus 3.59% of 613 news runs) with the release id attached, so a company measures itself against the vendors that actually hold the slots rather than against the outlets it assumed were being cited.

Related Reading

• Machine Relations: Why Media Relations Is Becoming Machine Relations in 2026
• Best Resources for Healthtech Company AI Visibility
• AI PR Software for Fintech Companies: What Actually Works in 2026

Sources and method

Every Index figure on this page is read from the live release pages at machinerelations.ai on September 19, 2026, release mri_score_v2.0+2026-09-19+0cad03121f60 (window 2026-05-10 to 2026-09-19, 15,883 monitored runs, 22,213 cited domains): the healthcare services category page and its seven segment pages (best tools, how buyers choose, top lists, news-driven citations, is it worth it, problem-first research, comparisons), and the domain profiles of nih.gov, nature.com, nejm.org, jamanetwork.com, sciencedirect.com, forbes.com, businessinsider.com, techcrunch.com, wired.com, fiercehealthcare.com, healthcaredive.com, beckershospitalreview.com, medcitynews.com, statnews.com, healthcareitnews.com, galengrowth.com, rockhealth.com, cbinsights.com, deloitte.com, gartner.com, mckinsey.com, forrester.com, cms.gov, fda.gov, tempus.com, aidoc.com, epic.com and abridge.com, each at https://machinerelations.ai/index/domains/<domain>. Segment standings are the release's own rank of total for each domain and segment; "not observed" is the absence of that domain from that segment's observed citations in the window, read per domain at its profile, which lists every segment the domain was observed in; "not observed in the release" is a domain whose profile route returns no profile because it is not among the 22,213 cited domains. The Index has no health AI category; healthcare services is the nearest measured category and the page says so. Third-party studies are linked inline to their pages at nature.com, techcrunch.com and cms.gov, read September 19, 2026.

---

AuthorityTech is the Machine Relations agency for AI-native companies building category authority. Get a free AI visibility audit to see where your healthcare AI company stands across AI engines.